However, only a few strains of A. marginale subspecies centrale are available for analysis. We Modulators suggest that resolution of this question should await genomic data on non-U.S. GSK2656157 manufacturer strains of both marginale and centrale, particularly strains from Africa. This would resolve whether there is a continuum of strain diversity among marginale strains eventually reaching that of the single currently sequenced centrale strain, originally isolated by Theiler in South Africa. A recent study [47] comparing membrane proteins from a Brazilian strain of A. marginale with Florida and St. Maries determined amino acid sequence

identities of 92–100% for all OMPs investigated except OMP7, compared to 40–70% identities with the A. marginale subspecies centrale orthologs. This suggests that the diversity observed here among U.S. strains of A. marginale may at least be representative of marginale strains in North and South

America. Finally, the data reveal the candidate vaccine antigens conserved among U.S. strains of A. marginale. The catalog includes conserved members of pfam01617, as well check details as components of the bacterial type 4 secretion system and proteins identified by surface cross-linking. Interestingly, it does include three proteins identified previously that contain epitopes shared with A. marginale subspecies centrale, namely OMP11 (AM1255), AM779 and AM854 [16]. However, overall the list is broader than just the antigens conserved between A. marginale sensu stricto and subspecies centrale. It also eliminates less conserved proteins and housekeeping genes which share epitopes between centrale and marginale. Additionally, although conserved, OMP6 and OPAG1 can probably be eliminated from consideration as vaccine candidates as no expressed peptides were detected from the encoding genes in any life cycle stages in prior studies [33] and [34]. This revised catalog of 19 antigens (see Table 4) would be readily approachable for synthesis by recombinant expression technology and inclusion in a multi-component 17-DMAG (Alvespimycin) HCl vaccine for testing. The present genomic data and previous experimental data suggest that

such a vaccine may be efficacious against U.S. strains of A. marginale. These data also illustrate the utility of next-generation sequencing techniques for identification of antigens and epitopes conserved between multiple strains. While rapid sequencing has been used extensively, this study shows its utility in examination of repetitive genes. While these techniques cannot yet assemble a genome through extensive repetitive regions, they can show regions where there is genetic similarity or where homologous regions are missing in newly sequenced strains. We thank Drs. Guy Palmer and Katherine Kocan for making available strains of A. marginale and Dr. Savita Shanker for supervision of library construction and pyrosequencing.